Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	1,506	1,506	1,459	1,525	1,153	851.4
Revenue Growth	3.26%	3.26%	-4.33%	32.18%	35.48%	19.55%
Gross Profit Gross Profit Growth	481.34	481.34	424.19	452.15	383.38	336
Operating Income Operating Income Growth	98.75	98.75	68.01	64.63	117.72	66.41
Net Income Net Income Growth	111	111	41.53	73.48	113.38	52.16
Earnings Per Share EPS Growth	4.69	4.69	1.76	3.11	4.79	2.21
EPS Growth	167.18%	167.18%	-43.49%	-35.15%	117.23%	-10.36%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	720.34	567.39	255.45	269.89
Export Export Growth	729.78	941.98	885.09	547.65
Unallocated Unallocated Growth	8.45	15.28	12.97	33.87
Total Total Growth	1,459	1,525	1,153	851.4

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	20.25	20.25	34.33	13.96	78.09	1.73
Total Debt Total Debt Growth	374.33	374.33	281.99	243.89	229.24	110.59
Net Cash (Debt) Net Cash Growth	-354.09	-354.09	-247.66	-229.93	-151.15	-108.86
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-14.96	-14.96	-10.47	-9.72	-6.39	-4.60

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	153.71	153.71	221.36	94.85	49.53	97.28
Capital Expenditures CapEx Growth	-249.03	-249.03	-218.6	-155.78	-67.19	-75.41
Free Cash Flow Free Cash Flow Growth	-95.32	-95.32	2.76	-60.93	-17.66	21.87
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	31.96%	31.96%	29.08%	29.66%	33.24%	39.46%
Operating Margin	6.56%	6.56%	4.66%	4.24%	10.21%	7.80%
Pretax Margin	7.28%	7.28%	2.85%	4.82%	10.07%	6.13%
Profit Margin	7.37%	7.37%	2.85%	4.82%	9.83%	6.13%
FCF Margin	-6.33%	-6.33%	0.19%	-4.00%	-1.53%	2.57%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	56.06	23.30	42.61	25.23	17.11	57.44
P/FCF Ratio	-	-	640.66	-	-	136.99
PS Ratio	4.13	1.72	1.21	1.22	1.68	3.52

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error